China SXT Pharmaceuticals Inc (SXTC)
1.04
-0.02
(-1.89%)
USD |
NASDAQ |
May 13, 16:00
1.04
0.00 (0.00%)
After-Hours: 20:00
China SXT Pharmaceuticals Total Liabilities (Quarterly): 9.512M for Sept. 30, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 9.512M |
| September 30, 2023 | 9.512M |
| March 31, 2023 | 14.86M |
| September 30, 2022 | 7.292M |
| September 30, 2022 | 7.292M |
| March 31, 2022 | 17.12M |
| September 30, 2021 | 8.879M |
| September 30, 2021 | 8.879M |
| March 31, 2021 | 18.59M |
| Date | Value |
|---|---|
| September 30, 2020 | 5.522M |
| September 30, 2020 | 5.522M |
| March 31, 2020 | 12.30M |
| September 30, 2019 | 11.64M |
| September 30, 2019 | 11.64M |
| March 31, 2019 | 6.363M |
| September 30, 2018 | 3.992M |
| September 30, 2018 | 3.992M |
| March 31, 2018 | 4.372M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
5.522M
Minimum
Sep 2020
18.59M
Maximum
Mar 2021
10.61M
Average
9.512M
Median
Sep 2023
Total Liabilities (Quarterly) Benchmarks
| Sinovac Biotech Ltd | 1.635B |
| CASI Pharmaceuticals Inc | 51.10M |
| Zai Lab Ltd | 226.27M |
| Gracell Biotechnologies Inc (DELISTED) | 36.85M |
| Adagene Inc | 45.17M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 14.59M |
| Shareholders Equity (Quarterly) | 5.076M |
| Debt to Equity Ratio | 0.5693 |
| Current Ratio | 1.467 |
| Net Debt Paydown Yield | -12.56% |